This event is archived. Final snapshot from when the story concluded. View on Dashboard
Tech medical breakthrough

Liver Enzyme Reverses Brain Aging

Analysis based on 12 articles · First reported Feb 18, 2026 · Last updated Feb 22, 2026

Sentiment
60
Attention
4
Articles
12
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

This medical breakthrough could significantly impact the biotechnology and pharmaceutical industries by opening new avenues for drug development targeting age-related cognitive decline and Alzheimer s disease. Companies focusing on these areas may see increased investment and research opportunities.

Biotechnology Pharmaceuticals Healthcare

Researchers at University of California, San Francisco have identified a biological process explaining how exercise benefits brain health, offering new avenues for protecting against neurodegenerative diseases like Alzheimer s disease. The study, published in the journal Cell, reveals that exercise prompts the liver to release an enzyme called GPLD1. This enzyme travels to the blood vessels surrounding the brain and removes a harmful protein, TNAP, from the surface of cells forming the blood-brain barrier. As people age, TNAP builds up, weakening the barrier and increasing leakiness, which leads to inflammation and cognitive decline. By reducing TNAP levels, GPLD1 helps restore the barrier's integrity, decrease inflammation, and improve memory. Experiments in older mice showed that reducing TNAP levels improved memory and cognitive function, suggesting potential therapeutic interventions even in later life. This discovery highlights a surprising body-to-brain pathway and could inspire new Alzheimer s disease therapies beyond traditional brain-focused strategies.

per
Saul Villeda, as the senior author of the paper and associate director of the UCSF Bakar Aging Research Institute, played a crucial role in this discovery, enhancing his professional standing and the visibility of his research.
Importance 70 Sentiment 20
per
Gregor Bieri, a postdoctoral scholar in Saul Villeda's lab and co-first author of the study, contributed significantly to the research, which will likely boost his academic career.
Importance 60 Sentiment 15
govactor
The United States===National Institutes of Health provided funding for the study, supporting critical medical research that could lead to new therapies.
Importance 20 Sentiment 10
ngo
The Simons Foundation contributed funding to the research, supporting advancements in understanding brain aging and potential Alzheimer s disease treatments.
Importance 15 Sentiment 10
ngo
The Cure Alzheimer s Fund supported the study, aligning with its mission to fund research for Alzheimer s disease.
Importance 15 Sentiment 10
govactor
The United States===National Science Foundation provided funding for the study, contributing to scientific understanding of age-related cognitive decline.
Importance 15 Sentiment 10
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.